Heather E. Fleming

Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens.

Development of Light-Activated CRISPR Using Guide RNAs with Photocleavable Protectors.

In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease.

In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites.

Protease activity sensors noninvasively classify bacterial infections and antibiotic responses.

Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers.

Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes.

Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling.

Controlled Apoptosis of Stromal Cells to Engineer Human Microlivers.

Microenvironment-triggered multimodal precision diagnostics.

Identification of NQO2 As a Protein Target in Small Molecule Modulation of Hepatocellular Function.

Synthetic Circuit-Driven Expression of Heterologous Enzymes for Disease Detection.

Virtual Undergraduate Research Experiences: More Than a Pandemic Stopgap.

A single-cell liver atlas of Plasmodium vivax infection.

A vascularized model of the human liver mimics regenerative responses.

Conditional Antimicrobial Peptide Therapeutics.

CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics.